News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
650,355 Results
Type
Article (53943)
Company Profile (137)
Press Release (596264)
Multimedia
Podcasts (109)
Webinars (20)
Section
Business (171689)
Career Advice (2713)
Deals (32574)
Drug Delivery (120)
Drug Development (75171)
Employer Resources (159)
FDA (15024)
Job Trends (13808)
News (301763)
Policy (29120)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2488)
Academic (2)
Accelerated approval (35)
Adcomms (28)
Allergies (146)
Alliances (42238)
ALS (169)
Alzheimer's disease (1556)
Antibody-drug conjugate (ADC) (299)
Approvals (15301)
Artificial intelligence (540)
Autoimmune disease (168)
Automation (40)
Bankruptcy (299)
Best Places to Work (10705)
BIOSECURE Act (15)
Biosimilars (181)
Biotechnology (91)
Bladder cancer (157)
Brain cancer (60)
Breast cancer (626)
Cancer (4747)
Cardiovascular disease (397)
Career advice (2314)
Career pathing (40)
CAR-T (289)
CDC (48)
Celiac Disease (2)
Cell therapy (770)
Cervical cancer (35)
Clinical research (64787)
Collaboration (1685)
Company closure (5)
Compensation (794)
Complete response letters (60)
COVID-19 (2502)
CRISPR (98)
C-suite (928)
Cystic fibrosis (142)
Data (6143)
Decentralized trials (1)
Denatured (40)
Depression (139)
Diabetes (471)
Diagnostics (6356)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (40)
Drug discovery (253)
Drug pricing (188)
Drug shortages (25)
Duchenne muscular dystrophy (222)
Earnings (63906)
Editorial (63)
Employer branding (21)
Employer resources (141)
Events (98125)
Executive appointments (1039)
FDA (18169)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1452)
Gene editing (208)
Generative AI (49)
Gene therapy (596)
GLP-1 (904)
Government (4682)
Grass and pollen (7)
Guidances (381)
Healthcare (17921)
HIV (60)
Huntington's disease (42)
IgA nephropathy (76)
Immunology and inflammation (230)
Immuno-oncology (61)
Indications (113)
Infectious disease (2767)
Inflammatory bowel disease (190)
Inflation Reduction Act (13)
Influenza (118)
Intellectual property (251)
Interviews (526)
IPO (14976)
IRA (46)
Job creations (3418)
Job search strategy (1912)
JPM (62)
Kidney cancer (17)
Labor market (82)
Layoffs (602)
Leadership (38)
Legal (6560)
Liver cancer (85)
Longevity (12)
Lung cancer (634)
Lymphoma (369)
Machine learning (42)
Management (52)
Manufacturing (763)
MASH (161)
Medical device (12925)
Medtech (12978)
Mergers & acquisitions (18711)
Metabolic disorders (1212)
Multiple sclerosis (156)
NASH (13)
Neurodegenerative disease (313)
Neuropsychiatric disorders (88)
Neuroscience (2781)
Neurotech (1)
NextGen: Class of 2026 (6266)
Non-profit (4189)
Now hiring (35)
Obesity (559)
Opinion (302)
Ovarian cancer (162)
Pain (202)
Pancreatic cancer (221)
Parkinson's disease (277)
Partnered (33)
Patents (506)
Patient recruitment (514)
Peanut (58)
People (59670)
Pharmaceutical (34)
Pharmacy benefit managers (27)
Phase 1 (20442)
Phase 2 (28569)
Phase 3 (20954)
Pipeline (5337)
Policy (275)
Postmarket research (2298)
Preclinical (8430)
Press Release (64)
Prostate cancer (245)
Psychedelics (43)
Radiopharmaceuticals (280)
Rare diseases (844)
Real estate (5966)
Recruiting (69)
Regulatory (22301)
Reports (41)
Research institute (2271)
Resumes & cover letters (408)
Rett syndrome (28)
RNA editing (16)
RSV (73)
Schizophrenia (149)
Series A (244)
Series B (182)
Service/supplier (8)
Sickle cell disease (96)
Special edition (20)
Spinal muscular atrophy (156)
Sponsored (41)
Startups (3267)
State (2)
Stomach cancer (13)
Supply chain (88)
Tariffs (72)
The Weekly (67)
Vaccines (967)
Venture capital (79)
Weight loss (345)
Women's health (88)
Worklife (21)
Date
Today (131)
Last 7 days (617)
Last 30 days (2203)
Last 365 days (28442)
2026 (3922)
2025 (28747)
2024 (32299)
2023 (36101)
2022 (46301)
2021 (51013)
2020 (50026)
2019 (43996)
2018 (33436)
2017 (30065)
2016 (29203)
2015 (34471)
2014 (27571)
2013 (23859)
2012 (25066)
2011 (25351)
2010 (23842)
Location
Africa (851)
Alabama (87)
Alaska (6)
Arizona (229)
Arkansas (14)
Asia (37981)
Australia (6656)
California (10421)
Canada (3059)
China (1064)
Colorado (440)
Connecticut (447)
Delaware (329)
Europe (88464)
Florida (1581)
Georgia (349)
Hawaii (3)
Idaho (57)
Illinois (857)
India (68)
Indiana (477)
Iowa (22)
Japan (412)
Kansas (120)
Kentucky (38)
Louisiana (27)
Maine (73)
Maryland (1285)
Massachusetts (7722)
Michigan (333)
Minnesota (563)
Mississippi (6)
Missouri (138)
Montana (34)
Nebraska (26)
Nevada (115)
New Hampshire (76)
New Jersey (2906)
New Mexico (30)
New York (2818)
North Carolina (1398)
North Dakota (9)
Northern California (5054)
Ohio (323)
Oklahoma (22)
Oregon (42)
Pennsylvania (2061)
Puerto Rico (23)
Rhode Island (44)
South America (1156)
South Carolina (51)
South Dakota (1)
Southern California (4126)
Tennessee (170)
Texas (1663)
United States (37680)
Utah (322)
Vermont (1)
Virginia (262)
Washington D.C. (69)
Washington State (858)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
650,355 Results for "blue cross blue shield of massachusetts".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Amgen Makes up to $840M Cancer Play With Dark Blue Takeover
The acquisition is centered on Dark Blue Therapeutics’ small-molecule degrader of the MLLT1 and MLLT3 proteins, which is being tested for acute myeloid leukemia.
January 7, 2026
·
1 min read
·
Tristan Manalac
Business
RUBY KAM JOINS BLUE CROSS BLUE SHIELD OF MASSACHUSETTS AS CHIEF FINANCIAL OFFICER
Ruby Kam has joined Blue Cross Blue Shield of Massachusetts (“Blue Cross”) as chief financial officer.
October 5, 2023
·
1 min read
Press Releases
Blue Genes Partners with RxSense to Deliver Actionable PGx at the Point of Adjudication
February 23, 2026
·
3 min read
Press Releases
HistoSonics Secures First Major Insurance Coverage for Non-Invasive Histotripsy Treatment for Liver Tumors With Blue Cross Blue Shield of Michigan
May 12, 2025
·
4 min read
BioMidwest
NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage
NeurAxis, Inc., a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, announced receipt of Blue Cross and Blue Shield of Kansas City policy coverage for approximately one million lives.
March 4, 2024
·
3 min read
Press Releases
AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE
January 7, 2026
·
8 min read
Press Releases
Dark Blue Therapeutics acquired by Amgen for up to $840 million
January 7, 2026
·
4 min read
BioMidwest
Relievant Medsystems Announces Positive Coverage Policy for the Intracept Procedure from Anthem Blue Cross and Blue Shield
Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low back pain, announced that Anthem Blue Cross and Blue Shield has established favorable coverage for the Intracept® Procedure.
October 3, 2023
·
3 min read
Biotech Bay
Guardant Health receives first commercial payor coverage for Guardant Reveal™ test from Blue Cross and Blue Shield of Louisiana
Guardant Health, Inc., a leading precision oncology company, announced that Blue Cross and Blue Shield of Louisiana now offers coverage for the Guardant Reveal™ molecular residual disease test.
July 20, 2023
·
4 min read
Press Releases
Breakthrough T1D Awards $1.5 Million Grant to Blue Circle Health to Expand Access to Care for Underserved Adults with Type 1 Diabetes
January 16, 2026
·
3 min read
1 of 65,036
Next
